wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28543212-2E11A60E-CF69-4E2A-81B5-79F394B43E6D
Q28543212-2E11A60E-CF69-4E2A-81B5-79F394B43E6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543212-2E11A60E-CF69-4E2A-81B5-79F394B43E6D
A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals
P2860
Q28543212-2E11A60E-CF69-4E2A-81B5-79F394B43E6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543212-2E11A60E-CF69-4E2A-81B5-79F394B43E6D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ea729eca698347440a7a243129d176a38b0bff1
P2860
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.